Specialty Pharmacy Distribution & Market Access Webinar

As Chief Brand Officer (CBO) at AscellaHealth, Mike supports the AscellaHealth Family of Companies comprehensive business strategy to increase brand awareness, boost perceived value and improve lines of services in the marketplace. He is responsible for oversight of our Family Companies based on sales & marketing to finance, client services and Specialty Pharmacy strategies throughout the organization that drive strategic business initiatives. Within his roles, he enhances the success of the strategic projects and applies business development, contract negotiations, network advancement, marketing & outreach strategies that cultivate opportunities for AscellaHealth and our Family of Companies.

Tiffany Ellen Burt is President and Chief Operating Officer (COO) of Optime Care, an AscellaHealth Company. In this role, she has overall responsibility for the management and strategic direction of Optime Care, with specific focus on developing new business development opportunities and partnerships as well as ongoing P&L execution. Tiffany comes to Optime Care with over 25 years of global healthcare and bio-pharmaceutical experience with a proven track record across pre-clinical, clinical and commercialization in early to late-stage Global Oncology and Rare Disease companies. She also exhibits deep leadership skills, building and leading teams, contributing to overall business growth.

Since 1995, healthcare, pharmaceutical, medical device, and biotech companies have looked to The Brooks Group to reinvent the way they do business. Across the healthcare landscape today, at the strategic level, all members of the value chain are focused on achieving the same objectives: Quintuple Aim: 1) Better Patient Experience; 2) Improved Population Health; 3) Bend the Per Capita Cost Curve Down; 4) Increased Provider Satisfaction; 5) Social Drivers of Health. We accomplish this by: Ensuring your customer facing teams possess the business skills & market knowledge to proactively access & engage key stakeholders. This provides superior insights, enabling them to build & position the unique value proposition that delivers mutual benefit to your Company, patients & customers. Ryan is the President of The Brooks Group. He has more than twenty-five years of successful experience in the healthcare industry. Today he specializes in market research, learning & development & consulting with pharmaceutical companies, Health Plans, PBMs, Specialty Pharmacies, IDNs & Providers to enable them to position their value proposition in the era of Quintuple Aim.

Dr. Emily K. Coriale, PharmD, has over 15 years executive leadership and consultative experience within the industry’s leading healthcare and pharmaceutical organizations. Her proven track record of leading the design of organizational structures and market design to support the strategy has enabled her to execute growth strategies while effectively managing medical and administrative expenses, resulting in exceeding overall margin targets. She has demonstrated exceptional relationship management and communication abilities among varied constituents, both internal and external, including healthcare professionals, community partners, or the public at large.